ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,869,000 | +34.4% | 16,670 | -2.0% | 0.01% | +50.0% |
Q2 2021 | $2,135,000 | -4.2% | 17,012 | +3.5% | 0.00% | 0.0% |
Q1 2021 | $2,229,000 | -0.4% | 16,434 | -6.1% | 0.00% | -20.0% |
Q4 2020 | $2,238,000 | +8.1% | 17,495 | -4.9% | 0.01% | 0.0% |
Q3 2020 | $2,071,000 | +27.1% | 18,404 | +7.6% | 0.01% | +25.0% |
Q2 2020 | $1,629,000 | -18.6% | 17,102 | -23.2% | 0.00% | -20.0% |
Q1 2020 | $2,001,000 | +72.1% | 22,270 | +1.5% | 0.01% | +150.0% |
Q4 2019 | $1,163,000 | +68.6% | 21,940 | +25.6% | 0.00% | 0.0% |
Q3 2019 | $690,000 | -3.9% | 17,475 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $718,000 | -8.4% | 17,475 | +3.8% | 0.00% | 0.0% |
Q1 2019 | $784,000 | +8.6% | 16,831 | +1.6% | 0.00% | 0.0% |
Q4 2018 | $722,000 | -21.5% | 16,574 | +3.1% | 0.00% | 0.0% |
Q3 2018 | $920,000 | +17.9% | 16,078 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $780,000 | +24.6% | 16,078 | +0.4% | 0.00% | +100.0% |
Q1 2018 | $626,000 | -7.9% | 16,011 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $680,000 | +24.5% | 16,011 | +9.5% | 0.00% | 0.0% |
Q3 2017 | $546,000 | +23.0% | 14,620 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $444,000 | +44.6% | 14,620 | +26.2% | 0.00% | 0.0% |
Q1 2017 | $307,000 | +3.7% | 11,582 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $296,000 | -29.4% | 11,582 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $419,000 | +6.3% | 11,582 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $394,000 | +49.2% | 11,582 | +15.8% | 0.00% | 0.0% |
Q1 2016 | $264,000 | -45.9% | 9,998 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $488,000 | +96.0% | 9,998 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $249,000 | -21.2% | 9,998 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $316,000 | -7.3% | 9,998 | +11.7% | 0.00% | 0.0% |
Q1 2015 | $341,000 | -2.3% | 8,951 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $349,000 | +28.8% | 8,951 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $271,000 | -88.5% | 8,951 | -87.1% | 0.00% | -80.0% |
Q2 2014 | $2,358,000 | +0.7% | 69,417 | +2.3% | 0.01% | 0.0% |
Q1 2014 | $2,341,000 | -58.7% | 67,866 | -52.6% | 0.01% | -61.5% |
Q4 2013 | $5,665,000 | – | 143,066 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,080,113 | $50,301,000 | 4.98% |
Foresite Capital Management II, LLC | 188,602 | $8,783,000 | 3.96% |
Artal Group S.A. | 1,650,000 | $76,841,000 | 3.14% |
Foresite Capital Management III, LLC | 254,923 | $11,872,000 | 3.09% |
Asymmetry Capital Management, L.P. | 30,125 | $1,403,000 | 2.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,255,174 | $58,453,000 | 2.24% |
QVT Financial LP | 190,977 | $8,894,000 | 2.24% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $12,546,000 | 1.51% |
Novo Holdings A/S | 198,261 | $9,233,000 | 1.37% |
FARALLON CAPITAL MANAGEMENT LLC | 2,375,000 | $110,604,000 | 0.83% |